Biocryst Pharmaceuticals (BCRX) Non-Current Deffered Revenue (2010 - 2026)

Biocryst Pharmaceuticals (BCRX) reported Non-Current Deffered Revenue of $8.8 million for Q1 2026, up 16253.7% quarter-over-quarter from $54000.0 in Q4 2018.

Biocryst Pharmaceuticals (BCRX) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends

Biocryst Pharmaceuticals has reported Non-Current Deffered Revenue for 10 years, with the latest figure at $8.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deffered Revenue changed N/A year-over-year to $8.8 million; the trailing twelve-month figure through Mar 2026 stood at $8.8 million (changed N/A YoY), and the FY2018 full-year result was $54000.0, down 65.16% from the prior year.
  • Non-Current Deffered Revenue for Q1 2026 stood at $8.8 million, up from $54000.0 in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $8.8 million in Q1 2026, with the low at $8.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Biocryst Pharmaceuticals 2.02 Bn 1.78 Bn 151.04 Mn 8.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.83 Mn
Dec 31, 2018 54,000.00
Sep 30, 2018 81,000.00
Jun 30, 2018 107,000.00
Mar 31, 2018 131,000.00
Dec 31, 2017 155,000.00
Sep 30, 2017 296,000.00
Jun 30, 2017 7.59 Mn
Mar 31, 2017 223,000.00
Dec 31, 2016 8.18 Mn
Sep 30, 2016 8.48 Mn
Jun 30, 2016 297,000.00
Mar 31, 2016 9.19 Mn
Dec 31, 2015 329,000.00
Sep 30, 2015 10.12 Mn
Jun 30, 2015 9.96 Mn
Mar 31, 2015 378,000.00
Dec 31, 2014 394,000.00
Sep 30, 2014 3.85 Mn
Jun 30, 2014 4.14 Mn